Objectives: To investigate appropriate antimicrobial agents, the optimal concentration and treatment duration for the antibiotic lock technique (ALT) to treat catheter-related infections caused by Staphylococcus epidermidis and Staphylococcus aureus.
Introduction
Catheter-related infections are significant problems in modern healthcare. More than half of catheter-related infections are caused by Gram-positive bacteria, most commonly Staphylococcus aureus and coagulase-negative staphylococci. 1 Catheter-related infections are associated with the establishment of microbial biofilms on the surface of catheters. [2] [3] [4] Treatment of these infections, with antibiotics to which the organism is susceptible according to conventional antimicrobial susceptibility testing, frequently fails. It has been demonstrated that antibiotic concentrations must be 100-1000 times greater to kill biofilm bacteria than to kill planktonic bacteria in solution. 5, 6 In many cases, the most effective treatment is the removal of the infected device and its replacement; however, this may be associated with significant technical problems and costs. 7 To improve bacterial eradication rates, the antibiotic lock technique (ALT) is recommended by the guidelines from the Infectious Diseases Society of America (IDSA) and the Centers for Disease Control and Prevention (CDC) as an effective therapeutic option for catheter-related infections. 8, 9 ALT consists of instilling a highly concentrated antibiotic solution into a catheter lumen and allowing the solution to remain in place for a period of time to sterilize the device. 10 Antimicrobial choices for ALT depend on different microbial pathogens, characteristics of infected pathogens and the pharmacodynamics of antimicrobial agents. Although treatment trials for catheter-related infection have been carried out using a variety of antimicrobial agents, 1, 11, 12 experimental evidence for the selection of antimicrobial agents and antimicrobial concentrations is limited.
This study evaluated the in vitro activity of ALT using a variety of antimicrobial agents to determine the optimal 
Materials and methods

Bacterial strains
Four Gram-positive bacterial strains were used in this study: two S. aureus (SA195 and SA204) and two S. epidermidis (ATCC 35983 and ATCC 35984) strains; these strains were isolated from patients with catheter sepsis and have been characterized as biofilm-forming strains. [13] [14] [15] [16] All four strains were resistant to oxacillin.
MICs and minimal bactericidal concentrations
The MIC was determined by the broth microdilution method using an inoculum of 5 · 10 5 cfu/mL. 17 S. aureus ATCC 29213 was used as a control. The MBC was determined from subcultures, on 5% sheep blood agar plates with 0.1 mL of each, from the control, the first tube with visible growth and all tubes without visible growth. MBC was defined as the lowest concentration of the antibiotic that reduced the original inoculum by ‡99.9%.
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Formation of bacterial biofilms
A polyurethane (PU) sheet was prepared by the method of Golomb and Shpigelman. 19 The sheet was cut into 1 · 1 cm square pieces and sterilized with ethylene oxide gas. Bacterial strains were grown on tryptic soy agar (TSA) plates at 37 C for 18-24 h. A 0.5 McFarland (about 10 8 cfu/mL) bacterial suspension was prepared and diluted using tryptic soy broth (TSB) supplemented with 0.25% sucrose to yield a final inoculum of 10 7 cfu/mL. PU pieces were immersed in 10 mL of the bacterial suspension and incubated at 37 C for 5 days on a shaker at 100 rpm to make mature biofilms. 15 
In vitro model of antimicrobial lock technique
The PU pieces with the bacterial biofilms were washed with PBS, and three PU pieces were incubated in TSB supplemented with 0.25% sucrose containing each of the following antibiotics: vancomycin, teicoplanin, ciprofloxacin, rifampicin, cefazolin, gentamicin, nafcillin and erythromycin. For the antimicrobial lock experiments, antimicrobial agents were used at concentrations of 1, 5 and 10 mg/ mL. Vancomycin and ciprofloxacin could not be tested at a concentration of 10 mg/mL because of precipitation. TSB without antibiotics was used as a control for each experiment. The bacterial killing activities of the antibiotic solutions were assayed after incubation for 1, 3, 5, 7, 10 or 14 days. Antibiotic solutions were refreshed every 48 h. The biofilm bacteria were quantified by the determination of viable counts. Antibiotic exposure was performed at 37 C. The PU pieces were removed from the bacterial culture and washed twice with 10 mL of sterile phosphate-buffered saline to remove planktonic bacteria and antimicrobial residue. Then, the washed PU pieces were subjected to a high-speed vortex in 3 mL of sterile PBS, followed by sonication using a VCX-400 sonicator (Sonics & Materials Inc., Danbury, CT, USA) (120 s, 30% cycle, pulse 3.5 s). Complete release of adherent bacteria, from PU pieces, was confirmed using scanning electron microscopy. The number of viable biofilm bacteria was counted by 10-fold serial dilution and plating on blood agar. The mean values for the biofilm bacteria in three separate runs were compared between groups for each antibiotic.
Results
MICs and MBCs
The MICs and MBCs of the antimicrobial agents for the four staphylococcal strains are shown in Table 1 . All four staphylococcal strains were methicillin-resistant and their mecA genes were confirmed using PCR. No strains were resistant to vancomycin, teicoplanin or rifampicin. While two S. aureus strains were resistant to ciprofloxacin, two S. epidermidis strains were susceptible to it. All four staphylococcal strains were resistant to cefazolin, erythromycin, nafcillin and gentamicin. No isolates showed tolerance to any of the antimicrobial agents tested in this study.
Effect of ALT against S. epidermidis and S. aureus
The mean viable count for the initial biofilm-formed S. epidermidis and S. aureus was found to be (1.3 -2.1) · 10 7 and (2.5 -0.6) · 10 6 cfu/sheet, respectively. For S. epidermidis, the PU films were sterile after 5 days of exposure to 5 mg/mL vancomycin, while 1 mg/mL vancomycin did not completely eradicate the bacteria even after a 2 week exposure (Tables 2 and 3 ). For S. aureus, PU films were sterile after treatment with 1 mg/mL as well as 5 mg/mL vancomycin for 5 days (Tables 4 and 5 ). The bactericidal activity of teicoplanin was more rapid in the treatment of S. aureus than of S. epidermidis. S. epidermidis biofilms were eliminated more rapidly than S. aureus by ciprofloxacin. Among the eight antimicrobial agents tested in this study, rifampicin was the most effective one for sterilizing biofilms. Most PU films became sterile the day after rifampicin exposure (except S. epidermidis with 1 mg/mL). Significant eradication of both S. epidermidis and S. aureus biofilms was not achieved with cefazolin, nafcillin, gentamicin or erythromycin at any of the time exposures examined (Figure 1 ).
Discussion
Catheter-related infections, which are associated with microbial biofilms on the surface of catheters, are an important cause of morbidity in patients. In addition, they prolong hospital stays, increase medical costs and may lead to premature removal of catheters. The ALT has been suggested as an option for treating catheter-related infections; however, experimental evidence for the selection of effective antimicrobial agents and antimicrobial concentrations, for treatment, has not been determined. Therefore, we studied the in vitro effectiveness of eight antimicrobial agents for the eradication of biofilms infected with S. epidermidis and S. aureus, the most common causative pathogens of catheterrelated infections. Although treatment trials for catheter-related infections have been carried out using a variety of antimicrobial agents, 1 the antimicrobial concentrations of the studied antibiotics have been selected arbitrarily by the investigators. A wide range of concentrations has been chosen for in vitro and clinical studies. A recent study suggested that for S. epidermidis-associated catheter infections, a 10 and 3 day antibiotic lock may be appropriate for vancomycin (10 mg/mL) and linezolid (2 mg/mL), respectively. 2 However, that study evaluated only one S. epidermidis strain; four antimicrobial agents (vancomycin, gentamicin, linezolid and eperezolid) were tested at a single concentration based on the suggested concentration of ALT (vancomycin and gentamicin) or on maximum solubility (linezolid and eperezolid). Thus, they could not obtain the optimal concentration for each antimicrobial agent for ALT. Another study by Monzón et al., 20 using a different in vitro model, reported that erythromycin, rifampicin and tetracycline showed bactericidal activities superior to that of vancomycin against an S. epidermidis strain. These investigators suggested that combinations of vancomycin with tetracycline or rifampicin may improve treatment against S. epidermidis biofilm bacteria. However, they could not propose the optimal duration and optimal concentration of the antimicrobial agents, because they used only the expected peak serum concentration.
In this study, we tested eight antimicrobial agents at different concentrations for the treatment of two strains of S. epidermidis and two strains of S. aureus (Figure 1 ). For vancomycin, 1 mg/mL was found to be inadequate for eradication of bacterial biofilms; however, 5 mg/mL vancomycin was efficient for eradication of biofilms of both staphylococcal species within 5 days. Vancomycin showed better killing activity in this study than previously reported. 2 This difference may be due to the different biofilm models. There is currently no universally accepted in vitro model for biofilm infection. There are several models used for simulation of catheter-related infections. 1, 2, 20, 21 Our model, using a simple technique with medical-grade PU films, simulates bacterial biofilms rescued by treatment with antibiotics. 14, 15 We attempted to avoid inter-experimental differences by performing experiments in triplicate. Furthermore, we used a more mature biofilm model (5 days versus 24 h for biofilm formation) compared with that of Curtin et al.
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For ALT, 1-5 mg/mL vancomycin is currently recommended for 10-14 days by current guidelines. 8, 9 However, our data suggest that 1 mg/mL vancomycin may not be sufficient and that the treatment duration with vancomycin might be further reduced for ALT. Teicoplanin showed comparable killing activity to vancomycin against S. aureus.
The present study showed that ciprofloxacin was superior to vancomycin for eradication of both S. epidermidis and S. aureus strains. Even 1 mg/mL ciprofloxacin killed S. epidermidis biofilms within 5 days; these strains were susceptible to ciprofloxacin. Both S. aureus strains, which were resistant to ciprofloxacin, were completely eradicated by 5 mg/mL ciprofloxacin within 3 days (Tables 4 and 5 ). This is in contrast to the failure of other antibiotics to which the strains were resistant, such as cefazolin, nafcillin, erythromycin and gentamicin, in sterilizing the biofilm bacteria. However, 5 mg/mL ciprofloxacin was 40 or 312 times the MIC for each strain. Although antimicrobial agents with high MICs and MBCs tended to show no significant biofilm eradication, the effectiveness of antimicrobial agents in ALT may not be associated with conventional resistance. 20 Ciprofloxacin has not been widely tested or used for ALT against staphylococci. Based on our data, ciprofloxacin could be considered as an alternative therapeutic option for treatment of catheter-related infections caused by staphylococci; it might be a better option in cases of mixed infections with staphylococci and Gramnegative bacilli. The potential activity of ciprofloxacin for the eradication of biofilms should be studied further. Rifampicin showed the most rapid bactericidal activity among antimicrobial agents tested in this study. Rifampicin has been documented as playing a unique role for sterilization of foreign bodies infected with S. aureus. 22 Rifampicin has been frequently used in combination therapy for the treatment of biofilm-related infections. However, rifampicin alone is not recommended for the treatment of staphylococcal infections because of the rapid emergence of resistance. 23 Because rifampicin rapidly eradicated biofilm bacteria during ALT, the chance of emergence of resistance might be very low; however, this requires further evaluation. Antimicrobials other than vancomycin and/or combinations of two or more antimicrobials should be investigated because of increasing antimicrobial resistance. 20, 21 The present study has some drawbacks. The four staphylococcal strains used in this study have similar antibiograms except for ciprofloxacin. Therefore, we could not estimate the effectiveness of each antibiotic against strains that are susceptible to it. Based on our data, there is a possibility that the conventional susceptibility of the organism is an important variable, even though ciprofloxacin was an exception. A methicillin-susceptible strain might be eradicated by cefazolin or nafcillin; this warrants further investigation.
In summary, our data suggest that a dose of at least 5 mg/mL vancomycin is needed for ALT; 5 mg/mL ciprofloxacin might be effective even in cases of ciprofloxacin-resistant strains and the treatment duration of ALT might be shorter than currently recommended. These findings now require prospective clinical trials for further evaluation of the clinical efficacy of ALT for less than 10 days with 5 mg/mL vancomycin, teicoplanin or ciprofloxacin for treating catheter-related infections caused by staphylococci.
